356 related articles for article (PubMed ID: 33098713)
1. Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: A Danish cohort study.
Nørgård BM; Nielsen J; Knudsen T; Nielsen RG; Larsen MD; Jølving LR; Kjeldsen J
Br J Clin Pharmacol; 2021 Apr; 87(4):2111-2120. PubMed ID: 33098713
[TBL] [Abstract][Full Text] [Related]
2. Paternal use of medications for inflammatory bowel disease and the risk of hospital-diagnosed infections in the offspring: a nationwide cohort study.
Friedman S; Garvik OS; Nielsen J; Nørgård BM
Aliment Pharmacol Ther; 2022 Sep; 56(5):823-830. PubMed ID: 35770457
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.
Yousaf A; Gayam S; Feldman S; Zinn Z; Kolodney M
J Am Acad Dermatol; 2021 Jan; 84(1):70-75. PubMed ID: 32926977
[TBL] [Abstract][Full Text] [Related]
4. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
[TBL] [Abstract][Full Text] [Related]
5. Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study.
Nørgård BM; Zegers FD; Nielsen J; Kjeldsen J
J Autoimmun; 2021 Dec; 125():102739. PubMed ID: 34757259
[TBL] [Abstract][Full Text] [Related]
6. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
Larsen MD; Friedman S; Magnussen B; Nørgård BM
Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
[TBL] [Abstract][Full Text] [Related]
7. Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.
Sun Y; Miller DC; Akpandak I; Chen EM; Arnold BF; Acharya NR
Ophthalmology; 2022 Oct; 129(10):1096-1106. PubMed ID: 35588945
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
[TBL] [Abstract][Full Text] [Related]
9. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study.
Attauabi M; Seidelin JB; Felding OK; Wewer MD; Vinther Arp LK; Sarikaya MZ; Egeberg A; Vladimirova N; Bendtsen F; Burisch J
J Autoimmun; 2021 Mar; 118():102613. PubMed ID: 33592545
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark.
Nørgård BM; Nielsen J; Friedman S
Aliment Pharmacol Ther; 2020 Sep; 52(5):829-842. PubMed ID: 32677731
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
[TBL] [Abstract][Full Text] [Related]
14. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
[TBL] [Abstract][Full Text] [Related]
16. Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy.
Bröms G; Granath F; Ekbom A; Hellgren K; Pedersen L; Sørensen HT; Stephansson O; Kieler H
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):234-41.e1-5. PubMed ID: 26375613
[TBL] [Abstract][Full Text] [Related]
17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days.
Karadag AS; Aslan Kayıran M; Lotti T; Wollina U
Dermatol Ther; 2020 Sep; 33(5):e13686. PubMed ID: 32458530
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
